Advertisement
U.S. markets open in 9 hours 2 minutes
  • S&P Futures

    5,129.00
    -9.25 (-0.18%)
     
  • Dow Futures

    38,954.00
    -68.00 (-0.17%)
     
  • Nasdaq Futures

    18,204.25
    -57.75 (-0.32%)
     
  • Russell 2000 Futures

    2,068.20
    -7.60 (-0.37%)
     
  • Crude Oil

    78.46
    -0.28 (-0.36%)
     
  • Gold

    2,124.40
    -1.90 (-0.09%)
     
  • Silver

    23.95
    -0.04 (-0.15%)
     
  • EUR/USD

    1.0855
    -0.0004 (-0.03%)
     
  • 10-Yr Bond

    4.2190
    -4.2190 (-100.00%)
     
  • Vix

    13.49
    -13.11 (-100.00%)
     
  • GBP/USD

    1.2686
    -0.0007 (-0.06%)
     
  • USD/JPY

    150.5050
    +0.0770 (+0.05%)
     
  • Bitcoin USD

    66,936.19
    +3,444.50 (+5.43%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,640.33
    -42.17 (-0.55%)
     
  • Nikkei 225

    40,206.65
    +295.85 (+0.74%)
     

U.S. firm Acorda to buy Finland's Biotie for $363 million

HELSINKI, Jan 19 (Reuters) - U.S. biotechnology company Acorda Therapeutics Inc. announced on Tuesday an agreed $363 million cash bid for all of the shares in Finland's Biotie Therapies.

Acorda said the acquisition would expand its pipeline in Parkinson's disease therapies.

The company will offer 0.294 euros for each Biotie share, a premium of about 95 percent compared with the closing price on Monday.

Biotie shares had jumped 79 percent to 0.27 euros by 0824 GMT.

(Reporting by Tuomas Forsell; Editing by Jussi Rosendahl and Mark Potter)

Advertisement